argenx to report full year 2019 financial results and fourth quarter business update on February 27, 2020
(WorldNews Netherlands)

argenx to report full year 2019 financial results and fourth quarter business update on February 27, 2020 20 Feb 2020 07:00 CET Company Name ARGENX SE ISN NL0010832176 Market Euronext Symbol ARGX argenx to report full year 2019 financial results and fourth quarter business update on February 27, 2020 February 20, 2020 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today announced that it will host a conference call and audio webcast on Thursday, February 27, 2020 at 3:00 pm CET (9:00 am ET) to...